Evidence map›Paper›PMID 40891847›Full record

ArticleApplied and environmental microbiology2025

A three-plasmid-containing CRISPR-Cas9 platform to engineer

Lian Li, Kecheng Luo, Shuangyu Zhang, Xiaohua Wang, Sihan Wang, Xuehui Liu, Shanshan Zang, Yuan Liu, Changyong Zhou, Chuping Luo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Characterization ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Journal of bacteriology · 2026
    Review
  3. Review
  4. Biocontrol strategies for fungal diseases ofFrontiers in microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lian LiJiangsu Provincial Key Construction Laboratory of Probiotics Preparation, Huaiyin Institute of Technology, Huaian, China.
Kecheng LuoJiangsu Provincial Key Construction Laboratory of Probiotics Preparation, Huaiyin Institute of Technology, Huaian, China.
Shuangyu ZhangJiangsu Provincial Key Construction Laboratory of Probiotics Preparation, Huaiyin Institute of Technology, Huaian, China.
Xiaohua WangJiangsu Provincial Key Construction Laboratory of Probiotics Preparation, Huaiyin Institute of Technology, Huaian, China.
Sihan WangJiangsu Provincial Key Construction Laboratory of Probiotics Preparation, Huaiyin Institute of Technology, Huaian, China.
Xuehui LiuInstitute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Shanshan ZangInstitute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Yuan LiuJiangsu Provincial Key Construction Laboratory of Probiotics Preparation, Huaiyin Institute of Technology, Huaian, China.
Changyong ZhouHuaiyin Academy of Agricultural Sciences, Huaian, China.
Chuping LuoJiangsu Provincial Key Construction Laboratory of Probiotics Preparation, Huaiyin Institute of Technology, Huaian, China.ORCID 0000-0002-3192-9889

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BacillusBiological Control AgentsCRISPR-Cas SystemsGene EditingPlasmidsBacterial ProteinsLipopeptidesOryzaPeptide SynthasesPlant DiseasesBacterial ProteinsBiological Control AgentsLipopeptidesnon-ribosomal peptide synthasePeptide Synthasesantagonistic activityBacillus velezensisbiocontrol efficiencyCRISPR-Cas9 platformcyclic lipopeptides

Identifiers

PMID40891847
PMCPMC12542745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.